Santori & Peters Inc’s Novo Nordisk NVO Stock Holding History

Santori & Peters Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-162	Closed	-$4K	–	380
2017 Q4	$4K	Buy	+162	New	+$4.12K	﹤0.01%	488

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Santori & Peters Inc's NVO Position: Q1 2018 in Review

Santori & Peters Inc sold out of Novo Nordisk (NVO) in Q1 2018, closing a stake of 162 shares — an estimated $4K sold.

Santori & Peters Inc first reported a position in NVO in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

Santori & Peters Inc reported no remaining Novo Nordisk position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 162 Novo Nordisk shares in Q1 2018, an estimated $4K.
Santori & Peters Inc first reported a position in Novo Nordisk in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's Novo Nordisk position peaked at $4K in Q4 2017.
553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.